INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Infections by human cytomegalovirus (CMV) are associated with congenital neurological complications in newborns and pneumonitis, retinitis, hepatitis, and gastrointestinal diseases in immunocompromised patients (1, 32). The virus replicates in fibroblasts, endothelial and epithelial cells, smooth muscle cells, neurons, glial cells, and macrophages (64, 69, 70, 89, 90). Productive infection is associated with terminal differentiation of the cell. During viremia, primitive hematopoietic cell populations of the bone marrow are also infected (28). Infected myeloid cell progenitors harbor both the latent viral genome and viral latency-associated transcripts (28, 38, 39). These transcripts originate within the major immediate-early (MIE) enhancer at 356 and 292 relative to the transcription start site for productive infection (+1) and are terminated at the immediate-early 1 (IE1) or IE2 polyadenylation signals (38, 39). Only a small portion of bone marrow mononuclear cells from naturally infected individuals express viral latency-associated transcripts, but the role of the viral proteins encoded by these transcripts is presently not understood (38, 39). Peripheral blood monocytes isolated from CMV-seropositive individuals also carry latent viral genomes (53, 66, 67, 85), but latency-associated transcripts have not been demonstrated in these cells.

Viral transcripts from the MIE promoter at +1 are associated with productive infection (77). Inflammatory cytokines such as gamma interferon can convert nonpermissive monocytes to permissive macrophages (71). They may also stimulate tissue dendritic cells to a permissive state for viral replication (28). In addition, monocyte-derived macrophages from seropositive individuals can be activated and differentiated by inflammatory cytokines plus allogeneic T cells to produce infectious virus (72). The switch from latent transcription to productive infection transcription is not understood, but it may be related to the state of cellular differentiation. As the monocyte differentiates, repressive chromatin structures may become less restrictive for productive viral transcripts and facilitate the switch from latent transcription to productive viral transcripts. A better understanding of the viral chromatin structure in this region of the viral genome may help elucidate viral reactivation mechanisms.

The first class of viral genes to be expressed after reactivation from latency or primary infection is the IE genes. There are two IE genes downstream of the MIE promoter, IE1 and IE2 (75, 77, 78). These genes code for proteins that regulate viral and cellular gene expression (31, 48, 74-76). The IE1 gene encodes a 491-amino-acid nuclear phosphoprotein of approximately 72 kDa (IE72). The viral gene is necessary for efficient viral replication at low multiplicities of infection, but it is not essential at high multiplicities (27, 54). The IE2 gene encodes several viral gene products (75). The largest viral protein is a 579-amino-acid nuclear phosphoprotein of approximately 86 kDa (IE86) which is presumably essential for viral replication because the viral gene cannot be deleted. These and the ancillary IE genes, UL36 through UL38 and IRS1/TRS1, affect the level of early gene expression (13). The early viral genes encode viral proteins involved in ori-Lyt-mediated viral DNA synthesis (2). The late viral genes are expressed after viral DNA replication and encode many of the viral structural proteins (23).

A genetic target for reactivation from latency or for efficient replication after primary infection is the MIE enhancer (8, 52, 80). The human (6, 86), simian (9), rat (63), and murine (17) CMV MIE enhancers are regarded as critical regulatory elements for reactivation from latency to productive infection. With murine CMV, the efficiency of viral replication in tissue culture or in the host is greatly impaired when the MIE enhancer is deleted, but infectious viruses can be produced, and consequently, the enhancer is not essential (3).

The human CMV MIE enhancer and the flanking regions were assigned arbitrary boundaries to better discuss this complicated regulatory region (52, 80). Downstream of the MIE +1 start site is a positive regulatory control region from +8 to +112 referred to as leader exon 1 (22). The MIE promoter between 50 and +8 contains a TATA box, a cis-repression sequence (crs) between 13 and 1, and an initiator-like sequence between +1 and +7 (46, 47, 52, 80). After expression of the downstream IE1-IE2 genes, the MIE promoter is negatively autoregulated by the IE86 protein (11, 44, 60). The IE86 protein binds to the crs and may interfere with the binding of a 150-kDa cellular transcription initiation factor (46). The IE86 protein and possibly the UL84 gene product (62), which interacts with IE86 at early and late times after infection, repress RNA polymerase II initiation at the MIE promoter (47, 91). The MIE enhancer between 550 and 50 has cis-acting elements in repetitive motifs which bind factors such as CREB/ATF, NF-B/rel, and SP-1 and in nonrepetitive motifs which bind AP-1, RA, SRE, and ETS. These cis-acting elements respond to a variety of signal transduction events which occur early after infection (4, 8, 52, 80). Upstream of the MIE enhancer between approximately 750 and 550 is a region referred to as the unique region (21, 52, 80). The region contains a cluster of CTF/NF-1 binding sites (29), but no function, to date, has been assigned to these sites or to this region. Deletion of the modulator region between 1108 and 750 had no effect on transcription from the MIE promoter in either infected undifferentiated or infected differentiated cells (51). This region is conserved in all human CMVs sequenced to date and is present in chimpanzee CMV (8). The region contains a 393-bp open reading frame (ORF) designated UL127, which is divergent from the MIE promoter and genes (10). A TATA box sequence is positioned 38 bp upstream of UL127. Although the viral gene product may be important to either viral latency or pathogenesis, it is nonessential for replication in cell culture (51).

The genomes of viruses such as simian virus 40, adenovirus, and adeno-associated virus do not exist in vivo as naked DNA but are in the form of nucleosomal structures separated by 40- to 50-bp stretches of naked DNA (14, 40, 49, 88). Little is known about the chromatin structure of herpesviruses. Although the genomes of herpes simplex virus and Epstein-Barr virus are in a nucleosome structure during latency (15, 18), this structure is altered during productive infection.

All herpesviruses encode virus-specific transcriptional regulatory proteins. These viral proteins function either by directly binding to the viral DNA or by interacting with other viral or cellular proteins. The net effect of these interactions could be a remodeling of viral chromatin to facilitate the expression of early viral genes. It has been proposed that the human CMV IE86 protein might activate viral as well as cellular promoters by inducing chromatin remodeling (37).

In this report, we describe a repressive sequence between the UL127 promoter and the MIE enhancer of human CMV that blocks transcription from the UL127 promoter at early and late times after infection of permissive human fibroblasts. When this regulatory viral DNA sequence in the unique region was replaced with nonregulatory stuffer DNAs and the UL127 ORF was replaced with the chloramphenical acetyltransferase (CAT) gene, there was very strong early transcription and downstream reporter gene expression from the wild-type UL127 promoter. Within the unique region, there are several cis sites with consensus or near-consensus sites for the binding of transcriptional repressor proteins. Mutation of the unique region between the UL127 promoter and the MIE enhancer may affect the binding of cellular proteins. Reasons why the expression of the UL127 gene is repressed in wild-type virus in permissive human fibroblasts during productive infection are discussed.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Cells and viruses. Primary human foreskin fibroblasts (HFFs) were grown in Eagle's minimal essential medium (Life Technologies, Gaithersburg, Md., or Mediatech, Herndon, Va.) supplemented with 10% newborn bovine serum (Sigma, St. Louis, Mo.), 100 U of penicillin per ml, and 100 µg of streptomycin per ml. The same conditions were used for the growth of fibroblasts with hypoxanthine guanine phosphoribosyltransferase deficiency (GM02291), which were obtained from the Coriell Institute for Medical Research (Coriell Cell Repositories, Camden, N.J.). Human CMV strain Towne and all recombinant viruses made from the Towne strain were propagated as described previously (81). All recombinant viruses grew as well as did the parent recombinant virus RdlMSVgpt(r1) (51). Titers of infectious virus in the extracellular fluid were determined on HFFs by plaque assay as described previously (51).

Enzymes. All DNA-modifying enzymes were used according to the manufacturers' specifications and were obtained from either New England Biolabs, Inc. (Beverly, Mass.), Bethesda Research Laboratories, Inc. (Gaithersburg, Md.), Boehringer Mannheim Biochemicals (Indianapolis, Ind.), or Promega (Madison, Wis.).

Plasmids. Since the transcription start site from the UL127 promoter had not been mapped precisely, the region of the viral genome between the putative UL127 promoter and the MIE promoter was designated relative to the transcription start site (+1) of the MIE promoter (52, 80). By using plasmid pLUX/CAT (36), HindIII restriction endonuclease sites were located downstream of the UL127 promoter at 706 and downstream of the MIE promoter at +171 to generate plasmid pLC3+. The resultant plasmid contains wild-type viral DNA sequence between the divergent UL127 and MIE promoters with the luciferase (LUX) and CAT indicator genes downstream, respectively. The following deletions upstream of the UL127 promoter were introduced into plasmid pLC3+. (i) An SpeI site was inserted at 694, and the region from 694 to 583 was deleted by restriction endonuclease digestion with SpeI. The ends were ligated with T4 DNA ligase to generate plasmid pLCdl694/583. (ii) To maintain the relative spacing between the UL127 promoter and the enhancer, heterologous DNA fragments of 116, 121, and 134 bp were isolated from plasmid pCAT-basic (Promega) after restriction endonuclease digestion with either ScaI/StyI, SalI/BanI, or BamHI/HincII, respectively. After each DNA fragment was made blunt with Klenow polymerase, the DNA fragments were ligated to the SpeI site at 583 of pLCdl694/583, which was made blunt with Klenow polymerase, to generate plasmids pLCdl694/583+116bp, pLC694/583+121bp, and pLCdl694/583+134bp, respectively. All plasmid constructions were sequenced by the dideoxynucleotide method.

Recombinant viruses. All recombinant viruses were made from the parental recombinant virus RdlMSVgpt(r1), which has a simian virus 40 early kinetic-class transcription unit containing the bacterial guanyl phosphoribosyltransferase (gpt) ORF in place of the deleted modulator region at 640 to 1108 relative to the MIE promoter start site (51). The shuttle vector pdlMCAT was constructed as described for pdlMSVgpt (46), except that the gpt gene was replaced by the CAT gene and the wild-type sequence (706 to +171) containing the UL127 putative promoter was located upstream of the CAT gene. A deletion upstream of the UL127 promoter between 694 and 583 was introduced into plasmid pdlMCAT as follows. Two oligonucleotides, 5'-CTAGTGCTATATAACCAAGCTTGCGATCAAGCTTATCGACT-3' and 5'-CTAGAGTCGATAAGCTTGATCGCAAGCTTGGTTATATAGCA-3', were annealed and ligated into the XbaI site (726) downstream of the UL127 promoter and the SpeI site (583) upstream of the UL127 promoter to generate shuttle vector pdlMCATdl694/583. DNA fragments of 116, 121, or 134 bp were isolated from pCAT-basic as described above. The DNA fragments were made blunt with Klenow polymerase and ligated into the SpeI site (583) of pdlMCATdl694/583, which was made blunt by Klenow polymerase, to generate shuttle vectors pdlMCAT+116, pdlMCAT+121, and pdlMCAT+134, respectively. Shuttle vectors pdlMCATTheta, pdlMCATdl694-640, and pdlMCATdl640-583 were constructed as follows. Plasmid pdlMCATTheta had a deletion between the XbaI site at 726 and the BsrGI site at 640 which caused a deletion of the UL127 promoter. Deletions between 694 and 640 and 640 and 583 were made by restriction endonuclease digestion with SpeI at 694 and BsrGI at 640 and digestion with BsrGI (640) and SpeI at 583, respectively.

Southern blots. Virus was isolated from the culture medium as described previously (81). The viral envelope was solubilized with 1% Sarkosyl, and viral proteins were digested with 200 µg of proteinase K per ml in 0.1% sodium dodecyl sulfate. Viral DNAs were digested with restriction endonucleases EcoRI and NdeI and fractionated by electrophoresis in 1.5% agarose gels. DNA probes were radioactively labeled by the Rediprime ³²P-label method of Amersham Pharmacia Biotech (Piscataway, N.J.). Consecutive hybridizations for Southern blot analysis were done as described previously (43, 51). Specific bands were visualized by autoradiography on Hyperfilm MP (Amersham).

Northern blots. Whole-cell RNA was isolated according to the method of Chomczynski and Sacchi (12). RNAs isolated from infected cells treated with cycloheximide (CH) (200 µg/ml) for 24 h or phosphonoacetic acid (PAA) (200 µg/ml) for 48 h or untreated for 48 h were designated IE, early, and late RNAs, respectively. RNAs were fractionated by electrophoresis in 1.5% agarose gels containing 6% formaldehyde and blotted onto Nytran as described previously (51). A gel-purified SpeI-EcoRV (174,310 to 174,645 map units) fragment was multi-prime ³²P-labeled for use as a UL127-specific probe with bidirectional hybridization potential. This same fragment was used to PCR generate, by the method of Bednarczuk et al. (5), the UL127-specific unidirectional ³²P-labeled probe from an oligonucleotide, 5'-CGCTATAAACGCTGTGTGTC-3', starting at 174,580 map units. Hybridization of ³²P-labeled probes was done at 68°C overnight as described previously (51). Probes were stripped from blots by boiling in 0.1× SSPE (1× SSPE is 0.18 M NaCl, 10 mM NaH₂PO₄, and 1 mM EDTA [pH 7.7]) containing 0.5% sodium dodecyl sulfate. Sense UL127 RNA was synthesized by cloning the UL127-containing template into pBluescript and using phage polymerase for in vitro RNA synthesis according to the instructions of Promega.

RNase protection assay. Riboprobe synthesis was performed by the method of Krieg and Melton (42) and as described previously (30). Cytoplasmic RNA was harvested from mock-infected or infected HFFs as described previously (87). The multiplicity of infection was approximately 5 PFU per cell. Twenty micrograms of RNA was hybridized to the ³²P-labeled riboprobes at room temperature overnight. The specific activities of the riboprobes were similar. After digestion with 100 U of RNase T₁ (Boehringer Mannheim) at 37°C for 1 h and then 65 µg of proteinase K for 15 min at 37°C, the RNAs protected from RNase digestion were fractionated in denaturing 6% polyacrylamide-urea gels. Signals were visualized by autoradiography on Hyperfilm MP (Amersham Pharmacia Biotech) and quantitated by image acquisition analysis.

Indicator gene product assays. All transfections were done three times in quadruplicate on 100-mm-diameter plates of confluent HFFs by the calcium phosphate precipitation method of Graham and van der Eb (25). All infections with recombinant viruses were done in triplicate on 100-mm-diameter plates of HFFs. CAT activities were determined in substrate excess as described by Gorman et al. (24). The acetylated and nonacetylated [¹⁴C]chloramphenicol was separated by thin-layer chromatography in a chloroform-methanol (95:5) solvent. The amount of [¹⁴C]chloramphenicol acetylation was determined by image acquisition analysis, and the protein concentration was determined by the Bradford method (Bio-Rad Laboratories, Richmond, Calif.). The mean percent acetylation of [¹⁴C]chloramphenicol was determined per microgram of protein lysate.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Lack of UL127 gene transcription. The approximately 200-bp region between the 5' end of the MIE enhancer (550 relative to the IE1 transcription start site) and the UL127 ORF (741) is referred to as the unique region (21, 52). Within this region is a consensus TATA box sequence that is identical to the TATA box of the divergent MIE promoter (Fig. 1A). The TATA box sequence is 38 bp upstream of the UL127 ORF in a position typical for a viral promoter. When approximately 100 bp of the unique region proximal to the UL127 ORF was deleted in the construction of recombinant virus RdlMSVgpt(r1) (Fig. 1A), there was no detectable effect on transcription from the MIE promoter (51). Transcription from the minimal simian virus 40 promoter at 640 allowed for expression of the downstream gpt gene substituted for the viral UL127 ORF (51). In addition, the proposed effect of the modulator, which was based on transient-transfection experiments, was not demonstrable in the context of the viral genome. Deletion of the modulator did not affect transcription from the MIE promoter in undifferentiated or differentiated cells (51). We were interested in determining if and when transcription from the putative UL127 promoter occurred in terminally differentiated HFF cells infected with wild-type human CMV Towne. HFFs were infected with either wild-type Towne virus or recombinant virus RdlMSVgpt(r1) at a multiplicity of infection of approximately 5 PFU/cell. We constructed bidirectional or unidirectional probes that span the junction between the unique region and the UL127 ORF as diagramed in Fig. 1A. Whole-cell RNA was isolated at various times after infection, fractionated by denaturing gel electrophoresis, and analyzed by Northern blot hybridization. The sensitivity of the Northern blot assay was evaluated by analyzing 2, 4, and 10 pg of in vitro-synthesized sense RNA from the UL127 ORF as described in Materials and Methods.

View larger version (55K): [in this window] [in a new window]   FIG. 1.   Northern blotting of viral transcripts from the unique region and the UL127 gene at various times after infection. (A) Diagram of the unique long (UL) and unique short (US) components of the human CMV (HCMV) genome flanked by terminal repeat (TR) or inverted repeat (IR) sequences containing an a sequence. An EcoRI restriction endonuclease map of the viral genome and the EcoRI region of the wild-type (WT) virus and recombinant virus RdlMSVgpt(r1) is diagramed. Mock, IE, early, and late total cell RNAs were isolated and subjected to Northern blot hybridization with either a 32P-labeled bidirectional probe (B) or a 32P-labeled unidirectional probe (C). To determine the sensitivity of this method, RNA was synthesized in vitro from the UL127 gene template and analyzed. Standard molecular size markers are indicated in kilobases. SV40, simian virus 40.

Activation of the UL127 promoter. We constructed expression plasmids containing the MIE enhancer and unique region flanked by the divergent MIE promoter and putative UL127 promoter, respectively, for the expression of the CAT gene or the LUX gene, respectively (Fig. 2). The cis-acting transcription elements in repeat motifs of 18, 19, and 21 bp, which contain NF-B/rel, CREB/ATF, and SP-1 binding sites, respectively, and the upstream RA, SRE, and ETS sites have been described previously (52, 80). The CTF/NF-1 binding sites in the unique region have also been described elsewhere (29). Since the start site of the MIE promoter was mapped precisely, all designations were relative to this start site, which was designated +1 (77). The TATA box sequence upstream of the UL127 ORF was between 703 and 697. We deleted 111 bp from 694 to 583 of the unique region and replaced the 111-bp region with nonregulatory stuffer DNAs of 116, 121, or 134 bp as diagramed in Fig. 2. The transcription start site from the putative UL127 promoter had not been mapped, and consequently, the region from 694 to 583 was estimated to be between approximately 26 and 137 upstream of the UL127 start site based on the data obtained for Fig. 4A. HFFs were transfected with 10 µg of the various expression plasmids, and the level of CAT from the MIE promoter or of LUX from the putative UL127 promoter was determined per microgram of protein lysate as described in Materials and Methods.

View larger version (20K): [in this window] [in a new window]   FIG. 2.   Relative LUX activity from the UL127 promoter in transiently transfected HFFs. CAT or LUX activity per microgram of protein was measured from the MIE promoter or the divergent UL127 promoter, respectively, as described in Materials and Methods. The cis-acting transcription factor binding sites in repeat and nonrepeat sequences have been described elsewhere (52, 79, 80, 82, 83). Plasmids containing wild-type viral DNA sequence, deleted DNA sequence, or substituted nonregulatory stuffer DNA sequence are indicated relative to the MIE promoter transcription start site. The approximate positions of the mutations relative to the putative UL127 transcription start are also indicated. CAT activity was similar for all expression plasmids as described in the text.

Recombinant viruses lacking 111 bp of the unique region. To test whether the 111 bp of the wild-type unique region had an effect on transcription from the UL127 promoter in the context of the viral genome, recombinant viruses with deletions and replacements of this 111-bp region were isolated and characterized. To facilitate recombinant virus characterization and in the event that overexpression of the UL127 ORF was deleterious to viral replication, the UL127 gene was replaced with the CAT gene. All recombinant viruses were derived from RdlMSVgpt(r1) (Fig. 1) by homologous recombination with the shuttle vectors described in Materials and Methods. We selected against the gpt gene product by using Lesch-Nyhan human fibroblasts and 6-thioguanine-containing medium as described previously (26). To characterize the recombinant viruses, viral DNAs were digested with restriction endonucleases EcoRI and NdeI and analyzed by Southern blot hybridization. The sizes of the expected DNA fragments are indicated in Fig. 3A. The radioactively labeled probes were either wild-type DNA from the unique region or heterogeneous DNA from plasmid pCAT-basic. The black bars in Fig. 3A indicate the region to which the ³²P-DNA probes hybridize. DNA probes of 116 and 134 bp, which were isolated from the CAT gene of pCAT-basic, were expected to hybridize to the region of substitution between 694 and 583 as well as to the CAT gene inserted into the virus by homologous recombination. The heterogeneous DNA isolated from the region upstream of the CAT gene in plasmid pCAT-basic for the 121-bp DNA was expected to hybridize only to the region of heterogeneous DNA substitution between 694 and 583. The wild-type DNA probe was expected to hybridize to DNA fragments of approximately 1,400, 650, and 550 bp after restriction endonuclease digestion of wild-type Towne strain, RdlMCATWT, and RdlMCATTheta DNAs. RdlMCATTheta has the UL127 promoter deleted. All DNA fragments obtained by EcoRI and NdeI restriction endonuclease digestion were of the appropriate size (Fig. 3B) as predicted in the diagram of Fig. 3A. A longer exposure of the autoradiogram was required to detect hybridization of the 116-bp probe to the CAT gene DNA fragment from RdlMCAT121. From two separate transfections with the shuttle vectors and the infectious RdlMSVgpt(r1) DNA, two to three recombinant viruses of each type were plaque purified and characterized as described above. The heterologous DNA substitutions caused no discernible phenotypic differences in viral growth or plaque size (data not shown).

View larger version (30K): [in this window] [in a new window]   FIG. 3.   Recombinant viruses with wild-type (wt or WT) or mutant DNA sequences upstream of the UL127 promoter. All recombinant viruses containing the CAT gene were derived from RdlMSVgpt(r1) by selection against the gpt gene product as described in Materials and Methods. (A) Diagram of the recombinant viruses with the MIE promoter and the downstream IE1 gene and the divergent UL127 promoter and the downstream CAT gene. Both promoters have identical TATA boxes. Sequences upstream of the UL127 promoter with either wild type or deleted and replaced with nonregulatory DNA sequence of either 116, 121, or 134 bp. The DNA fragment containing the UL127 promoter is deleted in recombinant virus RdlMCATTheta. The origins of probes for detection of wild-type and 116-, 121-, or 134-bp heterologous DNAs are designated. The predicted sizes of DNA fragments after EcoRI and NdeI restriction endonuclease digestion of recombinant viral DNAs are indicated in base pairs. HCMV, human CMV. SV40, simian virus 40. (B) Southern blot hybridization of wild-type (WT) Towne strain DNA and recombinant virus DNA digested with restriction endonucleases EcoRI and NdeI. 32P-labeled probes of wild-type and 116-, 121-, and 134-bp heterologous DNA sequences are indicated. Lanes: 1 to 6, viral DNAs from human CMV Towne strain and RdlMCATWT, -Theta, -116, -121, and -134, respectively; 1 to 4 (at right), viral DNA from human CMV Towne strain and RdlMCATWT, -Theta, and -134, respectively. Standard molecular size markers are indicated in base pairs.

Effect of a 111-bp deletion and replacement of the unique region in recombinant viruses. To test the effect of the unique region between 694 and 583 on transcription from the MIE promoter or the putative UL127 promoter in the context of the viral genome, HFFs were infected at approximately 5 PFU per cell with recombinant viruses RdlMCATWT, -116, -121, -134, and -Theta. Cytoplasmic RNA was harvested at various times after infection from cells treated or not treated with CH or PAA. The viral RNAs were detected by RNase protection assay with antisense IE1 or CAT-UL127 riboprobes as described in Materials and Methods.

View larger version (37K): [in this window] [in a new window]   FIG. 4.   Transcription from the MIE promoter or the UL127 promoter at various times after infection with recombinant viruses. Cytoplasmic RNA was isolated from either mock-infected or infected cells treated with CH or PAA or untreated for IE, early, or late times after infection, respectively. (A) RNase protection assay of IE1 or UL127-CAT RNA harvested at 6 h p.i. from nontreated or CH-treated cells. Lanes: 1, standard molecular weight markers (std) (in thousands); 2, mock-infected cell RNA; 3 to 7 and 8 to 12, infected cell RNA from RdlMCATWT, -116, -121, -134, and -Theta, respectively. A map of the riboprobe and the protected fragment is shown. nt, nucleotide; AS, antisense riboprobe. (B) RNase protection assay of IE1 or UL127-CAT RNA harvested at 24 or 48 h p.i. from nontreated or PAA-treated cells. Lanes: 1, IE1 probe without RNase; 2, standard molecular weight markers (std) (in thousands); 3, CAT-UL127 probe without RNase; 4, mock-infected cell RNA; 5 to 7, 8 to 10, and 11 to 13, infected cell RNA from RdlMCATWT, -121, and -Theta, respectively. CAT-UL127 and IE1 RNase-protected RNA are indicated.

Expression of the CAT gene downstream of the UL127 promoter. We had demonstrated previously that the UL127 gene is nonessential for replication in HFFs (51). The above results demonstrate that UL127 is not expressed in HFFs. After infection of HFFs with RdlMCATWT, -116, -121, -134, and -Theta at approximately 5 PFU per cell, infected cells were harvested and analyzed for CAT expression at various times after infection. CAT activity was determined as percent acetylation per microgram of protein as described in Materials and Methods.

View larger version (33K): [in this window] [in a new window]   FIG. 5.   Expression of the CAT gene downstream of the UL127 promoter at various times after infection with recombinant viruses containing wild-type (WT), promoterless, or substituted heterologous DNA sequence upstream of the UL127 promoter. The recombinant viruses are as described for Fig. 3. CAT activity was determined as percent acetylation per microgram of protein-infected cell lysate as described in Materials and Methods.

Effect of approximately 50-bp deletions in the unique region. To further characterize the repressive region, deletions from 694 to 640 or 640 to 583 were made. These viruses were derived by homologous recombination between shuttle vectors and infectious viral DNA from recombinant virus RdlMSVgpt(r1) and by selection against gpt-expressing virus in infected Lesch-Nyhan cells as described in Materials and Methods. After plaque purification of the recombinant viruses, the viral DNAs were isolated and digested with restriction endonucleases EcoRI and NdeI and analyzed by Southern blot hybridization. Figure 6A is a diagram of the recombinant viruses, and the expected viral DNA fragment sizes produced after digestion with EcoRI and NdeI are indicated. The approximately 50-bp deletions should generate DNA fragments of 592 bp for the 694 to 640 deletion and 589 bp for the 640 to 583 deletion. Wild-type DNA probe from 686 to 583 should hybridize to either DNA fragment after EcoRI and NdeI digestion of the recombinant viral DNAs.

View larger version (28K): [in this window] [in a new window]   FIG. 6.   Recombinant viruses with approximately 50-bp deletions upstream of the UL127 promoter. All recombinant viruses containing the CAT gene were derived from RdlMSVgpt(r1) by selection against the gpt gene product as described in Materials and Methods. (A) Diagram of the recombinant viruses with the MIE promoter and the downstream IE1 gene and the divergent UL127 promoter and the downstream CAT gene. Approximately 50-bp deletions between 694 and 640 or 640 and 583 are indicated. The origin of a probe for detection of wild-type (WT or wt) DNA is designated. The predicted sizes of DNA fragments after EcoRI and NdeI restriction endonuclease digestion of recombinant viral DNAs are indicated in base pairs. HCMV, human CMV. SV40, simian virus 40. (B) Southern blot hybridization of wild-type Towne strain DNA and recombinant viral DNAs digested with restriction endonucleases EcoRI and NdeI and fractionated by agarose gel electrophoresis as described in Materials and Methods. Lanes: 1, human CMV Towne strain; 2, RdlMCATWT; 3, RdlMCAT694-640A; 4, RdlMCAT694-640B; 5, RdlMCAT640-583A; 6, RdlMCAT640-583B; 7, RdlMCAT640-583C. Numbers at left indicate molecular sizes in kilobases.

View larger version (62K): [in this window] [in a new window]   FIG. 7.   Effect of either the proximal or distal deletions of approximately 50 bp on transcription from the UL127 promoter at early times after infection. Infected cell RNA was isolated at 6 h p.i. and analyzed as described in the legend to Fig. 4. Lanes: 1, standard molecular weight markers (std) (in thousands); 2, mock-infected cell RNA; 3, infected cell RNA from RdlMCATWT; 4 to 7, infected cell RNA from RdlMCAT694-640A, -B, -C, and -D, respectively; 8 and 9, infected cell RNA from RdlMCAT640-583A and -C, respectively; 10, IE1 probe not treated with RNase; 11, CAT-UL127 probe not treated with RNase; CAT-UL127 and IE1 RNase-protected RNAs are indicated.

View larger version (22K): [in this window] [in a new window]   FIG. 8.   Expression of the CAT gene downstream of the UL127 promoter at various times after infection with recombinant viruses containing proximal or distal deletions of approximately 50 bp upstream of the UL127 promoter. The recombinant viruses are as described for Fig. 6. CAT activity was determined as percent acetylation per microgram of protein of infected cell lysate as described in Materials and Methods.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

In the human CMV genome, like the murine CMV genome, the MIE enhancer is flanked by divergent promoters (Fig. 1). With human CMV, efficient transcription occurs from only the MIE promoter at +1 in permissive HFFs and not from the divergent promoter upstream of the UL127 gene. In contrast, the murine CMV MIE enhancer influences transcription from both divergent promoters in permissive cells. We hypothesized that human CMV is different from murine CMV because human CMV has regions that prevent divergent transcription in permissive cells. After extensive deletion analysis and transient-transfection assays in HFFs, we located a regulatory region between the UL127 TATA box and the MIE enhancer. When the wild-type sequences between 694 and 583 were deleted or replaced with nonregulatory stuffer DNAs, we found that the UL127 promoter was now driving transcription. Deletion of this region caused a significant increase in the basal activity of the divergent UL127 promoter in transient-transfection assays but had no effect on the MIE promoter.

In cells infected with recombinant viruses, the UL127 promoter was repressed by the wild-type sequences at all times after infection and was activated only when the wild-type sequence was replaced with different nonregulatory stuffer DNAs. Although the UL127 promoter was not converted to an IE promoter, it was a highly inducible early promoter that required viral protein synthesis for activation. Subsequent deletion analysis indicated that the region immediately upstream of the UL127 TATA box, between 694 and 640, had the major negative regulatory effect on transcription from the UL127 promoter at early times after infection.

DNase I footprinting assays of the unique region that lies upstream of the MIE enhancer have detected the binding of cellular factors present in transcriptionally active nuclear extracts (21). Since chromatin structure is known to have a role in transcriptional regulation, one or more of these cellular DNA binding proteins may repress transcription from the UL127 promoter at early times after infection. As a result, the region could constitute a boundary between the UL127 promoter and the MIE enhancer that functions to repress transcription from the UL127 promoter at early times after infection of permissive HFFs. Deletion of 54 bp between 694 and 640 had the most significant effect on transcription from the UL127 promoter at early times. Deletion of 57 bp between 640 and 583 had less of an effect on transcription from the UL127 promoter. These two regions were referred to as the proximal and distal negative regulatory regions, respectively.

Whether expression of the UL127 ORF is repressed when wild-type virus infects cells that favor latency is presently not known. It is tempting to speculate that expression of the UL127 gene is latency specific like that of the UL126 gene (39). In this regard, our analysis also detects little to no initiation of transcription from the 356 and 292 latency-associated transcription start sites for expression of the UL126 gene during productive infection of HFFs (50). An examination of the proximal and distal regions upstream of the UL127 promoter identified several cis sites for the binding of known transcriptional activator or repressor proteins. Within both the proximal and distal human CMV unique regions are NF-1 binding sites (Fig. 2). The NF-1 DNA binding protein family has been implicated in both positive and negative regulation of cellular and viral promoters (19, 35, 58, 59, 61). Our additional deletion analysis indicates that the NF-1 sites do not regulate repression of transcription from the UL127 promoter (data not shown). Immediately upstream of the UL127 TATA box between 690 and 680 is a consensus binding site for members of the winged-helix transcriptional regulatory protein family (Fig. 9). Winged-helix proteins are a family of transcriptional activator and repressor proteins found in mammalian cells. Winged-helix proteins are preferentially expressed in undifferentiated stem cells and not in differentiated cells (84). Therefore, it is possible that the winged-helix transcriptional activator may induce expression of the UL127 gene in the myeloid cell-committed progenitors. There are also winged-helix repressor proteins. The winged-helix repressor protein termed genesis (HFH-2) is a critical mammalian cell-regulatory factor in embryonic differentiation (84). HFH-2 protein binding sites are found upstream of a number of developmentally regulated promoters, and HFH-2 expression is restricted to primitive embryonic stem cells (84). Since winged-helix activators and repressors are found preferentially in undifferentiated cells, whether this site has a role in repression of the UL127 promoter in differentiated HFF cells remains to be determined. There is also a near-consensus suppressor of hairy wing (suHW) binding site in the proximal region (Fig. 9). In Drosophila melanogaster, suHW can block the effect of an enhancer on a promoter (73). Although there are mammalian cell proteins related to suHW, their role as repressors of transcription is not understood. In addition, within both the proximal and the distal unique regions, there are human papillomavirus type 16 (HPV-16) silencing motifs (Fig. 9). This element was identified as a 9-bp sequence with a critical core sequence that binds an unknown human transcriptional repressor protein (57). The element is located within the HPV-16 origin of DNA replication between the HPV-16 enhancer and the E6/E7 promoter. In transient-transfection assays, two elements are necessary for efficient repression of the E6/E7 promoter (57).

View larger version (16K): [in this window] [in a new window]   FIG. 9.   Diagram of the region between the UL127 promoter and the MIE enhancer demonstrating putative binding sites for winged-helix transcriptional repressor, NF-1, suHW, and the HPV silencing motif (PSM).

It is possible that a combination of different host cell repressor proteins binds cooperatively to the unique region of human CMV to prevent transcription from the UL127 promoter in permissive HFFs. This region of the human CMV genome may serve as a boundary to suppress the transcription-activating effects of the extremely strong MIE enhancer region from the UL127 promoter and to inhibit the effects of the viral IE transactivators on this promoter.

When the human CMV unique region was deleted, the UL127 promoter behaved like an early viral promoter. The viral IE1 and IE2 gene products are regulatory proteins that enhance transcription from both cellular and viral promoters (7, 20, 31, 33, 48, 55, 76). In recombinant virus-infected cells, we assume that the viral gene products of IE1 and IE2 and possibly UL36- to -38 and TRS1/IRS1 were necessary for the activation of this promoter since the UL127 promoter was not activated without de novo viral protein synthesis.

A viral factor that controls the activity of the MIE promoter is the IE2 gene product, IE86 (46, 47). The viral autoregulatory protein binds to the crs (Fig. 2) and inhibits transcription from the MIE promoter (46, 47). Maximum expression of the IE1 and IE2 genes occurs within 5 to 6 h after infection. In the recombinant viruses with wild-type sequence upstream of the UL127 promoter, the autoregulation at the crs of the MIE promoter was not sufficient to shift the effects of the MIE enhancer to the divergent UL127 promoter. In contrast, recombinant viruses lacking the wild-type regulatory sequence had very strong transcription from the UL127 promoter at 5 to 6 h after infection. Compared to IE1 transcription, which served as an internal control, the UL127 promoter was strongly activated relative to other early viral promoters such as UL4 (data not shown). Our data suggest that elements at the 5' end of the MIE enhancer and the unique region bind repressor proteins. The putative viral or cellular repressor proteins that bind to the unique region may dominate both the effects of the MIE enhancer and the viral transactivators that activate early viral promoters.

There are several proposed repressor elements within the MIE enhancer that were detected by transient-transfection assays. These include the YY1 sites (41, 45, 68), Gfi-1 sites (92), and the RA sites (80) (Fig. 2). One or more of these elements could affect the IE transcription from the MIE promoter as well as the UL127 promoter. However, the functionality of these elements in the context of the viral genome has not been tested. In addition, the region between 1140 and 750 was termed the modulator because the region differently affected transcription from the MIE promoter in various cell types in transient-transfection experiments (34, 56, 65). However, when this region was deleted in the context of the viral genome, there was no detectable effect on transcription from the MIE promoter in different cell types infected with the recombinant viruses (51). With the recombinant viruses used in this study, the modulator, which also contains the UL127 ORF, was replaced with an indicator gene to facilitate characterization of the regulatory elements upstream of the UL127 promoter. Therefore, it was not determined whether the modulator also affects transcription from the UL127 promoter at IE or early times after infection.

We propose that the unique region of the viral genome between the UL127 promoter and MIE enhancer contains sites for the binding of either viral or cellular repressor proteins. While we have discussed possible cellular protein binding sites, we have not eliminated viral protein binding sites. Viral proteins could be bound to the unique region as the viral genome enters the nucleus, or cellular proteins could bind to the unique region as the viral DNA enters the nucleus. Alternatively, the unique region could serve to anchor the human CMV genome to matrix proteins associated with transcription domains within the nucleus. The type of cellular proteins that bind to this region may differ depending on the cell type. The nature of the viral or cellular proteins that bind to this regulatory region remains to be determined.